They Missed Out. Now They’re Making Up for Lost Time.

For millions of Americans, obesity made ordinary things feel out of reach. Not impossible. Just costly enough, in discomfort and self-consciousness, that over time they stopped trying. The camping trip. The beach. The concert. The fitting room. The date. Over time, the nos accumulated into a life that was smaller than the one they wanted.

That is changing. A medication arrived that is giving people access to experiences they had set aside. The data on what they are doing with that access is specific, large, and almost entirely misread.

According to KFF’s November 2025 Health Tracking Poll, 18% of U.S. adults have taken a GLP-1 drug at some point and 12% are currently using one, an increase of 6 percentage points from eighteen months prior. Walmart spent 2025 and early 2026 building the infrastructure of that journey: pharmacy access, Better Care Services, Sam’s Club’s oral Wegovy program at $149 a month, a wellness destination spanning supplements to fresh food. Walmart is where the GLP-1 journey often starts. The question for suppliers is whether they are in the aisle when the rest of the journey begins.

The Money Didn’t Disappear. It Went Somewhere Specific.

Within six months of starting a GLP-1 medication, households reduce grocery spending by an average of 5.3%, with higher-income households cutting more than 8%, according to Cornell University research using Numerator’s transaction data from roughly 150,000 U.S. households. Spending at fast-food restaurants and coffee shops falls by roughly 8%. Savory snacks decline by about 10%, with similarly large drops in sweets, baked goods, and cookies.

That contraction is real. It is not, however, what most suppliers think it is. It is not a shrinking consumer. It is a consumer whose spending is reorganizing around a completely different life. Numerator’s GLP-1 Trends Hub, tracking quarterly purchases from more than 30,000 consumers, found that weight-loss-focused users increased spending on protein shakes by 38%, superfoods by 58%, and bone health products by 23% relative to comparable non-user households.

Among GLP-1 users specifically, formal-wear sales surged 80% and sporting goods jumped 24% in the first six months of 2025 compared with the same period the prior year, according to Consumer Edge credit and debit card data. Formal wear is not a fitness category. It is a showing-up category: the person who lost 60 pounds buying a suit for the job interview they can now imagine attending, or the reunion they are finally ready to go to. The sporting goods number is the same impulse, different merchandise. Hiking boots, a fishing rod, a bike, a tent. Things for experiences that had been set aside.

Suppliers who are reading these numbers as a demand story are missing the point. This is an identity story. The basket is changing because the person has changed, not because their appetite has been suppressed. The suppliers who understand that distinction will be in the right categories with the right positioning. The ones who don’t will be managing markdown on the wrong inventory while this consumer shops past them.

Ready to Date. Ready to Be Looked At.

The Kinsey Institute’s 2025 nationally representative study of 2,000 single adults found that 59% of GLP-1 users reported at least one change in their dating life since starting the medication, and men were three times more likely than women to report increased confidence in their appearance and more matches on dating apps.

A person re-entering the social and romantic world after years of holding back is not buying a functional product. They are buying the experience of feeling like themselves again. Fragrance. Body wash that smells like something worth noticing. Skincare that feels worth the attention. Cosmetics for a version of themselves they are newly comfortable presenting. Intimate apparel they want to wear. These purchases are powered by something much older and more urgent than a wellness trend.

Circana’s research explicitly identifies skin care, fragrance, makeup, and beauty products as experiencing measurable upticks from GLP-1 users who are proud of their progress. Suppliers whose beauty positioning speaks to the experience of feeling confident and seen are addressing a need that very few national brands are currently articulating clearly at Walmart’s price tier. Those that aren’t are leaving the purchase to whoever happens to be on the shelf.

There Are Two Beauty Problems, and Most Suppliers Are Solving Neither

Alongside the confidence story runs a distressed counterpart that requires a completely different brief.

Clootrack’s analysis of nearly 96,000 GLP-1 consumer conversations found that cosmetic interventions are the fastest-growing theme in GLP-1 appearance-related data, surging at 927.8% month-over-month. The driver is what consumers describe as facial hollowing, loss of cheek fullness, increased skin laxity, and looking older despite significant weight loss, with 85% of those mentions carrying negative sentiment. This is not a consumer browsing for enhancement. It is a consumer who lost 70 pounds, expected to feel beautiful, and instead found their face had changed in ways they weren’t prepared for. They are problem-solving, and doing it in Walmart’s beauty aisle with whatever the shelf offers.

The products they need are firming serums, collagen-support formulations, neck and jawline treatments, and volume-restoring products designed for structural skin changes after rapid weight loss. The standard anti-aging assortment was not built for this situation. The supplier who writes product positioning explicitly to this problem, post-weight-loss skin support at accessible price points, has a clear brief, an active searcher, and almost no competition. That gap will not stay open. The suppliers filling it now will own the association when the category gets crowded.

Walking First. Everything Else Follows.

The first thing most of these consumers do physically is walk. Not because they lack ambition, but because walking is the first activity that becomes genuinely available as the body changes. Clootrack found that walking is the most frequently referenced activity in its analysis of nearly 96,000 GLP-1 consumer conversations, with mobility restoration showing 95.7% positive sentiment and 120.4% month-over-month growth.

What those conversations describe is not fitness enthusiasm. It is the particular satisfaction of doing something that recently felt hard and finding it easier. The progression is physical but it is also emotional, and as it happens, a specific set of purchases follows: shoes that support joints adjusting to a lighter load, hydration products because every GLP-1 clinical protocol recommends increased water intake, trekking poles, socks designed for distance.

These are participation purchases, not performance purchases. A walking shoe marketed to a competitive runner is invisible to this consumer. A walking shoe framed around going further than you have in years, around comfort for a body in transition, is exactly what they are looking for. The supplier who understands that framing difference is not fighting for share against athletic brands. They are serving a customer those brands are not even speaking to.

Clootrack also found that anxiety about muscle loss is a fast-growing theme in GLP-1 conversations, with high growth and predominantly negative sentiment, meaning demand is forming from worry rather than ambition. Clinical guidance for GLP-1 patients specifically recommends resistance exercise to preserve lean mass. Resistance bands, adjustable dumbbells, and entry-level strength equipment at the $30 to $80 price point Walmart carries are the direct answer. The framing that works is not transformation. It is preservation. Suppliers in this space who are not yet speaking to that anxiety are not competing with the right message.

CivicScience data shows GLP-1 users are 23% more likely to exercise at a gym rather than at home, which points toward broader participation in activities that require gear. The progression is visible in the spending data: walking leads to hiking, hiking leads to camping, cycling, fishing, kayaking. A consumer buying a tent after significant weight loss is not an outdoor enthusiast upgrading their kit. They are going on the camping trip they had been declining for years. They need gear that is light, accessible, and priced for someone not yet sure how often they will use it. They are not going to REI. They are on Walmart.com at night, having finally decided to say yes. The 3P seller whose listing they find when they get there will earn a customer who is just beginning to spend.

The Food Suppliers Who Moved First Are Already Winning

The grocery basket shift is not coming. It is here, and the early positioning is largely done.

Conagra launched “GLP-1 Friendly” badges on 26 Healthy Choice products at Walmart starting January 2025, becoming the first major food brand to label explicitly for this consumer. Abbott introduced Protality nutrition shakes designed for GLP-1 users and began selling multi-packs at Walmart. General Mills’ Fiber One added GLP-1 support messaging to packaging. These suppliers made a decision about which consumer they were serving and moved toward them. The shelf position they now hold, associated in the GLP-1 consumer’s mind with products that support their journey, will not be easily displaced.

Circana identifies deli and produce as gaining share among GLP-1 users, deli because it offers portion control that pre-packaged goods can’t match, produce because it delivers the fiber and whole foods healthcare providers are recommending. Snack bars, yogurt, sports drinks, and low-sugar carbonated beverages are also growing in share. These are not abstract trends. They describe what someone rebuilding their relationship with food actually puts in the cart when appetite is no longer the loudest signal in the room.

Center-store staples built around calorie density are softening. Suppliers in those categories who have not yet mapped the GLP-1 household’s trajectory into their JBP planning are not just missing an opportunity. They are walking into a line review without an answer to a question their merchant already has data on.

The alcohol story completes the picture of where spending is going. EY-Parthenon’s March 2025 survey found that among GLP-1 users who reduced alcohol consumption, wine showed the steepest decline at 52%, followed by beer at 43% and spirits at 40%. That money is moving toward non-alcoholic beverages: sparkling waters, functional drinks, electrolyte products. The consumer who has stopped drinking wine at dinner is in the beverage aisle looking for something to put in the glass instead. The supplier whose product is there, positioned around hydration and wellness rather than deprivation, is having a different conversation with them than the supplier who is not there at all.

What the JBP Conversation Should Actually Sound Like

For 1P suppliers, the line review is the moment of reckoning. Circana projects that GLP-1 households, currently 23% of all U.S. households, will represent 35% of all food and beverage units sold by 2030 and 37% of non-food units. That is not a trend to monitor. That is a structural shift in who Walmart’s highest-spending customers are and what they are buying. Suppliers who arrive at the JBP with a basket-level analysis that segments GLP-1 households from non-GLP-1 households, names which column their category sits in, and proposes a specific response are demonstrating the kind of customer understanding that earns trust and shelf space. Suppliers who don’t have that analysis are hoping their merchant hasn’t noticed the data already sitting in Retail Link.

For 3P Marketplace sellers, the window is open but it is not wide open. CivicScience data shows GLP-1 users are 7 points more likely to use shopping as a form of self-care, meaning they have started to treat the acquisition of products as an expression of the new self they are building. The seller who is in their search results with the right product and the right language will earn the review, the ranking, and the repeat customer. Walking footwear, entry-level outdoor gear, resistance equipment, GLP-1-adjacent nutrition, post-weight-loss beauty, fragrance, personal care: in all of these categories, a well-positioned 3P seller at Walmart’s price tier is currently facing thin national-brand competition. That will change. The sellers who build position now are defending ground. The sellers who wait are fighting for it.

One channel consideration that belongs in every supplier’s planning: Circana found that GLP-1 users’ spending during their first year of active medication tends to shift away from mass and dollar stores and toward club stores and e-commerce retailers. Sam’s Club’s aggressive investment in GLP-1 pharmacy access, member pricing, and pharmacist-led wellness support positions it directly in that channel preference. Walmart.com captures the e-commerce shift. Suppliers whose activation plan relies primarily on supercenter foot traffic should understand where this consumer is actually choosing to shop.

What They Are Actually Buying

Strip away the basket data, the category analysis, and the channel strategy, and you are left with something simple.

The person buying formal wear is buying the event they can now imagine attending. The person buying a tent is buying the camping trip they have been saying no to for three years. The person buying fragrance is buying the date they are finally ready to go on. The person buying walking shoes is buying the daily experience of a body that is becoming more capable. Weight loss, improved health, body image, self-confidence, quality of life: a 2025 real-world patient survey published in medRxiv found these are the five reasons people stay on GLP-1 medication. Every one of them has a commercial expression at Walmart.

J.P. Morgan estimates that approximately 25 million Americans will be on GLP-1 treatment by 2030, up from around 10 million today. Walmart built the on-ramp. The suppliers who understand what those 25 million people are reaching for, and who have positioned their products, their listings, and their JBP arguments to meet that reaching, are going to look very smart in three years. The ones still talking only about size curves are going to be explaining to their merchants why they didn’t see it coming. The data was there. The story was obvious. They just hadn’t looked up from the apparel numbers long enough to read it.

Winning With Walmart

Winning With Walmart is an independent platform for suppliers, sellers, solution providers, and industry experts.

Articles are developed by staff editors, contributing experts, and trusted partners.

Some are researched and drafted with the assistance of AI tools and are reviewed, fact-checked, and edited by Winning With Walmart editors before publication.

Editorial judgment, sourcing decisions, and final approval rest with the publication's human editors in every case.

We are committed to accuracy and fairness. If you believe this article contains an error, we welcome your feedback.